HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Renaissance/MEM acquisition

This article was originally published in The Rose Sheet

Executive Summary

Renaissance/MEM acquisition: MEM shareholders approve purchase of company by Renaissance Cosmetics. The two firms reached an agreement in principle June 24 under which Renaissance would purchase MEM's approximately 2.6 mil. outstanding shares for $7.50 a share ("The Rose Sheet" July 1, p. 1). The deal is expected to close within 30 days, subject to financing and "certain regulatory approvals," MEM said...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003400

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel